Sanara MedTech (SMTI) Competitors $28.41 +0.05 (+0.18%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$28.42 +0.01 (+0.04%) As of 06/27/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. MDXG, INMD, BBNX, KMTS, IRMD, SIBN, CBLL, EMBC, AVNS, and RXSTShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include MiMedx Group (MDXG), InMode (INMD), Beta Bionics (BBNX), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), CeriBell (CBLL), Embecta (EMBC), AVANOS MEDICAL (AVNS), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors MiMedx Group InMode Beta Bionics Kestra Medical Technologies iRadimed SiBone CeriBell Embecta AVANOS MEDICAL RxSight Sanara MedTech (NASDAQ:SMTI) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Is SMTI or MDXG more profitable? MiMedx Group has a net margin of 11.40% compared to Sanara MedTech's net margin of -12.48%. MiMedx Group's return on equity of 22.70% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-12.48% -29.22% -13.20% MiMedx Group 11.40%22.70%16.77% Which has stronger earnings & valuation, SMTI or MDXG? MiMedx Group has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M2.91-$9.66M-$1.34-21.20MiMedx Group$348.88M2.51$42.42M$0.2722.00 Do institutionals and insiders have more ownership in SMTI or MDXG? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by company insiders. Comparatively, 1.7% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor SMTI or MDXG? In the previous week, MiMedx Group had 4 more articles in the media than Sanara MedTech. MarketBeat recorded 5 mentions for MiMedx Group and 1 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 1.87 beat MiMedx Group's score of 0.68 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Very Positive MiMedx Group Positive Do analysts prefer SMTI or MDXG? Sanara MedTech currently has a consensus target price of $49.50, suggesting a potential upside of 74.23%. MiMedx Group has a consensus target price of $12.50, suggesting a potential upside of 110.44%. Given MiMedx Group's higher possible upside, analysts clearly believe MiMedx Group is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, SMTI or MDXG? Sanara MedTech has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.83, meaning that its stock price is 83% more volatile than the S&P 500. SummaryMiMedx Group beats Sanara MedTech on 11 of the 14 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$252.57M$10.44B$5.46B$8.92BDividend YieldN/A2.10%5.35%4.14%P/E Ratio-21.2017.8226.1519.64Price / Sales2.9131.06410.74112.88Price / CashN/A23.5625.7827.49Price / Book6.383.637.875.41Net Income-$9.66M$235.40M$3.16B$248.99M7 Day Performance2.12%2.56%2.60%2.85%1 Month PerformanceN/A1.78%5.36%5.49%1 Year Performance0.67%-11.58%31.74%16.97% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech2.1945 of 5 stars$28.41+0.2%$49.50+74.2%+0.7%$252.57M$86.67M-21.2060Positive NewsHigh Trading VolumeMDXGMiMedx Group3.557 of 5 stars$5.94+2.2%$12.50+110.4%-14.3%$858.15M$352.38M22.00870News CoverageINMDInMode3.6762 of 5 stars$13.49+1.6%$18.54+37.4%-22.2%$839.42M$394.82M5.79480BBNXBeta BionicsN/A$15.80-11.7%$23.44+48.4%N/A$775.64M$65.12M0.00294KMTSKestra Medical TechnologiesN/A$16.00+6.5%$27.50+71.9%N/A$771.77MN/A0.00300High Trading VolumeIRMDiRadimed4.6968 of 5 stars$59.49+2.1%$72.00+21.0%+38.5%$740.53M$73.24M38.38110Positive NewsSIBNSiBone4.1053 of 5 stars$16.52+0.8%$22.50+36.2%+42.5%$698.45M$167.18M-25.81350CBLLCeriBell2.7416 of 5 stars$18.49+3.2%$32.50+75.8%N/A$647.32M$65.44M0.00N/AAnalyst ForecastEMBCEmbecta4.4202 of 5 stars$9.82+0.5%$19.33+96.9%-22.9%$570.98M$1.12B10.912,100News CoverageNegative NewsAVNSAVANOS MEDICAL2.834 of 5 stars$12.09-0.4%N/A-38.7%$561.40M$687.80M-1.442,227RXSTRxSight2.9577 of 5 stars$13.54-0.5%$37.90+179.9%-78.9%$553.07M$139.93M-20.21220Positive News Related Companies and Tools Related Companies MiMedx Group Competitors InMode Competitors Beta Bionics Competitors Kestra Medical Technologies Competitors iRadimed Competitors SiBone Competitors CeriBell Competitors Embecta Competitors AVANOS MEDICAL Competitors RxSight Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMTI Stock Alerts